Using two techniques for electrically stimulating parts of the brain, Cricia Rinchon is exploring the possibility that if they are stimulated, the cells that make up a network in the brain will work together to correct the damage Parkinson’s disease has done. As an undergraduate studying neuroscience at Western University, nearly every course Cricia Rinchon … Read more
At the Université du Québec à Montréal, PhD candidate Pierre-Alexandre Bourgouin studies the connection between a sleep disorder called idiopathic REM behaviour disorder and Parkinson’s disease. Bourgouin, a neuropsychologist, uses an imaging technology to search for changes in the white matter in the brains of people with this disorder, which can cause them to be … Read more
Atypical parkinsonisms are defined as neurodegenerative conditions that are not Parkinson’s disease. Progressive supranuclear palsy (PSP) and multiple system atrophy (MSA) are neurodegenerative disorders that can mimic Parkinson’s disease in the early stages, but have their own unique features, symptoms and treatment options. Both PSP and MSA are uncommon, each affecting five or six individuals out of … Read more
Accessibility & Neurological Conditions – Improving comfort for people with invisible disabilities while in the workplace and on route. This free webinar, by Neli Gontier, will offer tools, tips and resources for employers and transit authorities to comply with the Accessibility for Ontarians with Disabilities Act and better serve Ontarians living with neurological diseases. *Free* … Read more
End-of-Year Tax Receipts as per Canada Revenue Agency requirements Donations received by mail Donations must be postmarked by Canada Post as of December 31, 2018. A postmark date after December 31st requires us to issue a charitable tax receipt for the following year. Donations made by telephone/fax Any donation made over the telephone or by … Read more
People living with Parkinson’s likely have invisible disabilities and face many barriers as they go about their daily lives. Invisible disabilities include sight, hearing, learning, and speech impediments; diabetes; anxiety; chronic pain; sleep disorders and chronic fatigue. Ontario was the first province in Canada and one of the first jurisdictions in the world, to enact … Read more
Dr. Martin Parent, an associate professor at Laval University’s Department of Psychiatry and Neuroscience, is studying the cause of dyskinesia, uncontrolled movements that are a side effect of the levodopa therapy that is still the best drug treatment for Parkinson’s disease. He and his colleagues will be using an innovative new gene-editing technology to manipulate the … Read more
Up to 20 percent of people with Parkinson’s disease who take a new class of drugs to help reduce their stiffness, shakiness, slowness or unsteadiness have encountered an unwanted side-effect: impulsivity. Although the drugs, ropinirole and pramipexole, are effective at reducing motor control problems, the unwanted impulsivity can lead people into destructive behaviours. At the … Read more